After ‘most damaging period in FDA history,’ Makary will be hard to replace
With Commissioner Marty Makary’s exit, the FDA will enter a period of “unprecedented” and “prolonged” leadership vacuum, analysts at Capital Alpha predicted, noting that the government will have trouble finding someone who will want to take the FDA’s reins.
After ‘most damaging period in FDA history,’ Makary will be hard to replace Read More »
